NGM BIOPHARMACEUTICALS INC Research and Development Expense
NGM BIOPHARMACEUTICALS INC reported Research and Development Expense of $118.04 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2023-12-31 was $21.89M, a 53.15% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2023-09-30 was $22.94M, a 50.24% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2023-06-30 was $32.35M, a 28.79% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2023-03-31 was $40.86M, a 4.55% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC research and development expense for fiscal 2023 was $118.04M, a 34.81% decline from fiscal 2022.
- NGM BIOPHARMACEUTICALS INC research and development expense for fiscal 2022 was $181.07M, a 11.97% increase from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC research and development expense for fiscal 2021 was $161.71M, a 1.38% decline from fiscal 2020.
- NGM BIOPHARMACEUTICALS INC research and development expense for fiscal 2020 was $163.97M, a 26.86% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $21.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $44.83M derived: sum of 2 quarters · filed 2024-03-11 | $77.18M derived: sum of 3 quarters · filed 2024-03-11 | $118.04M 10-K · filed 2024-03-11 |
| 2023-09-30 | $22.94M 10-Q · filed 2023-11-02 | $55.29M derived: sum of 2 quarters · filed 2023-11-02 | $96.15M 10-Q · filed 2023-11-02 | $142.87M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | $32.35M 10-Q · filed 2023-08-03 | $73.21M 10-Q · filed 2023-08-03 | $119.93M derived: sum of 3 quarters · filed 2024-03-11 | $166.04M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | $40.86M 10-Q · filed 2023-05-04 | $87.58M derived: sum of 2 quarters · filed 2024-03-11 | $133.69M derived: sum of 3 quarters · filed 2024-03-11 | $179.12M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | $46.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $92.83M derived: sum of 2 quarters · filed 2024-03-11 | $138.26M derived: sum of 3 quarters · filed 2024-03-11 | $181.07M 10-K · filed 2024-03-11 |
| 2022-09-30 | $46.11M 10-Q · filed 2023-11-02 | $91.54M derived: sum of 2 quarters · filed 2023-11-02 | $134.34M 10-Q · filed 2023-11-02 | $173.07M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $45.43M 10-Q · filed 2023-08-03 | $88.24M 10-Q · filed 2023-08-03 | $126.97M derived: sum of 3 quarters · filed 2024-03-11 | $165.68M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $42.81M 10-Q · filed 2023-05-04 | $81.53M derived: sum of 2 quarters · filed 2024-03-11 | $120.25M derived: sum of 3 quarters · filed 2024-03-11 | $163.82M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $38.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $77.44M derived: sum of 2 quarters · filed 2024-03-11 | $121.01M derived: sum of 3 quarters · filed 2024-03-11 | $161.71M 10-K · filed 2024-03-11 |
| 2021-09-30 | $38.71M 10-Q · filed 2022-11-03 | $82.28M derived: sum of 2 quarters · filed 2022-11-03 | $122.98M 10-Q · filed 2022-11-03 | $163.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $43.57M 10-Q · filed 2022-08-04 | $84.27M 10-Q · filed 2022-08-04 | $124.33M derived: sum of 3 quarters · filed 2023-02-28 | $171.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $40.70M 10-Q · filed 2022-05-05 | $80.76M derived: sum of 2 quarters · filed 2023-02-28 | $127.74M derived: sum of 3 quarters · filed 2023-02-28 | $166.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $40.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $87.04M derived: sum of 2 quarters · filed 2023-02-28 | $125.53M derived: sum of 3 quarters · filed 2023-02-28 | $163.97M 10-K · filed 2023-02-28 |
| 2020-09-30 | $46.98M 10-Q · filed 2021-11-04 | $85.47M derived: sum of 2 quarters · filed 2021-11-04 | $123.91M 10-Q · filed 2021-11-04 | $165.87M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $38.49M 10-Q · filed 2021-08-05 | $76.93M 10-Q · filed 2021-08-05 | $118.89M derived: sum of 3 quarters · filed 2022-03-01 | $147.84M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $38.44M 10-Q · filed 2021-05-06 | $80.39M derived: sum of 2 quarters · filed 2022-03-01 | $109.35M derived: sum of 3 quarters · filed 2022-03-01 | $138.16M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $41.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $70.91M derived: sum of 2 quarters · filed 2022-03-01 | $99.73M derived: sum of 3 quarters · filed 2022-03-01 | $129.25M 10-K · filed 2022-03-01 |
| 2019-09-30 | $28.95M 10-Q · filed 2020-11-12 | $57.77M derived: sum of 2 quarters · filed 2020-11-12 | $87.30M 10-Q · filed 2020-11-12 | $116.24M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $28.82M 10-Q · filed 2020-08-12 | $58.35M 10-Q · filed 2020-08-12 | $87.29M derived: sum of 3 quarters · filed 2021-03-15 | $111.76M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $29.53M 10-Q · filed 2020-05-13 | $58.47M derived: sum of 2 quarters · filed 2021-03-15 | $82.94M derived: sum of 3 quarters · filed 2021-03-15 | $105.79M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $28.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $53.41M derived: sum of 2 quarters · filed 2021-03-15 | $76.26M derived: sum of 3 quarters · filed 2021-03-15 | $95.71M 10-K · filed 2021-03-15 |
| 2018-09-30 | $24.47M 10-Q · filed 2019-11-12 | $47.32M derived: sum of 2 quarters · filed 2019-11-12 | $66.77M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $22.85M 10-Q · filed 2019-08-12 | $42.30M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $19.45M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | $79.74M 10-K · filed 2020-03-17 |